KLRS · Kalaris Therapeutics, Inc. · Documents
Market Cap
$56.18M
Shares
23.80M
Volume · Oct 12
122.09K
Avg daily vol (3M)
250.65K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-08-11 | — | |
| 8-K | 2026-07-20 | 2026-07-14 | |
| 8-K | 2026-07-17 | — | |
| 8-K | 2026-07-06 | 2026-07-03 | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-24 | 2026-06-03 | |
| 8-K | 2026-04-10 | 2026-04-08 | |
| 8-K | 2026-03-17 | — | |
| 10-K | 2026-03-17 | 2025-12-31 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2025-12-18 | 2025-12-17 | |
| 8-K | 2025-12-17 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-03 | 2025-10-28 | |
| 8-K | 2025-08-13 | 2025-08-12 | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| DEF 14A | 2025-07-01 | 2025-08-12 | |
| 8-K | 2025-06-20 | 2025-06-19 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| 8-K | 2025-04-16 | 2025-04-10 | |
| 8-K | 2025-04-04 | 2025-04-03 | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-03-12 | — | |
| 10-K | 2025-03-07 | 2024-12-31 | |
| 8-K | 2025-01-15 | — | |
| 8-K | 2025-01-10 | 2025-01-09 | |
| 8-K | 2025-01-10 | 2025-01-09 | |
| 8-K | 2024-12-20 | 2024-12-19 | |
| DEF 14A | 2024-12-06 | 2025-01-09 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-08 | 2024-11-07 | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-07-02 | 2024-07-01 | |
| 8-K | 2024-06-11 | 2024-06-05 | |
| 8-K | 2024-06-07 | 2024-06-06 | |
| 8-K | 2024-06-03 | 2024-05-31 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| DEF 14A | 2024-04-23 | 2024-06-06 | |
| 10-K | 2024-03-15 | 2023-12-31 | |
| 8-K | 2024-02-12 | 2024-02-09 | |
| 8-K | 2024-01-04 | 2024-01-01 | |
| 8-K | 2023-12-22 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-11-02 | — |
Showing 1–50 of 105 filings